Formurex
Stockton, CA, United States formurex.com From their website, Nov 2026
- GLP
- GMP
Work here? Claim this listing
About
Formurex is a pharmaceutical contract research organization in Stockton, California. It provides preformulation, formulation development, analytical, stability, and GMP manufacturing services for the pharmaceutical and biotech industry, including early-stage clinical trial materials and controlled substances.
Services
Preformulation
Prepares and characterizes drug candidates to support early pharmaceutical development.
Formulation Development
Develops dosage forms and drug delivery formulations for pharmaceutical and biotech clients.
Analytical
Provides analytical testing and support for product development and manufacturing.
Stability
Conducts stability studies in a dedicated stability lab.
GMP Manufacturing
Performs GMP manufacturing for early-stage clinical trial materials and controlled substances.
CDMO: development & manufacturing
Clinical Trial Materials (CTM) Manufacturing
Manufactures early-stage clinical supplies for phase 1 clinical trials.
CDMO: development & manufacturing
Spray-Drying
Offers spray-drying capabilities as part of product development support.
Quality Control (AQC)
Provides analytical and quality control laboratory support.
Capabilities
- Assays and studies
- HPLC
- Quality control
- Scale and capacity
- About 8000 square feet facility
- 80 equipments under GLP/GMP
- Controlled access GMP manufacturing suites for Phase 1 Clinical Supplies and Controlled Substances
Instruments and platforms
- HPLC
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
As listed: GMP (GMP manufacturing suites for Phase 1 Clinical Supplies and Controlled Substances)
GLPSelf-reported
Scope: equipment and manufacturing facility
Industries served
- Pharmaceutical
- Biotech
Details
- Type
- CRO
- Founded
- 2009
- Address
- 2470 Wilcox Road, Stockton, CA 95215
- Serves
- Pharmaceutical and biotech industry
- Phone
- 209-931-2040
Public records
- FDA drug establishment registration
- ANALYSIS source